Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association - 1 Mar 2007

Kolwankar Dhanashri, Vuppalanchi Raj, Ethell Brian, Jones David R, Wrighton Steven A, Hall Stephen D, Chalasani Naga

Abstract excerpt

BACKGROUND & AIMS: Comorbidities associated with nonalcoholic fatty liver often require therapy with medications (eg, statins) metabolized by cytochrome P-450 3A (CYP3A). There is significant interindividual variability in CYP3A expression. However, human studies that systematically examined the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy, Needle
Share to Cytochrome P-450 CYP3A

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 Enzyme System

Share to Fatty Liver

Share to Probability

Share to Reference Values

Share to Sampling Studies

Share to Severity of Illness Index

Source

Identifiers

PMID: 17368239
DOI: 10.1016/j.cgh.2006.12.021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17368239-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity.PMID 17368239Read ↗

Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.Semantic proximity Read ↗

Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?Semantic proximity Read ↗

Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C.Semantic proximity Read ↗

Steatosis in chronic hepatitis C: why does it really matter?Semantic proximity Read ↗

Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients.Semantic proximity Read ↗

Association between MTTP genotype (-493G/T) polymorphism and hepatic steatosis in hepatitis C: a systematic review and meta-analysis.Semantic proximity Read ↗

Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C.Semantic proximity Read ↗

Genetic variation in the microsomal triglyceride transfer protein (-493G/T) is associated with hepatic steatosis in patients infected with hepatitis C virus.Semantic proximity Read ↗

Significantly reduced cytochrome P450 3A4 expression and activity in liver from humans with diabetes mellitus.Semantic proximity Read ↗

Hepatic steatosis in Iranian patients with chronic hepatitis C.Semantic proximity Read ↗

Steatosis affects chronic hepatitis C progression in a genotype specific way.Semantic proximity Read ↗

Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.